An essential role of PRMT1-mediated EGFR methylation in EGFR activation by ribonuclease 5.
Year: 2019
Type: article
Abstract: Methylation at Arg198 and Arg200 residues of the EGFR extracellular domain by PRMT1 have been demonstrated to enhance EGFR activation by the canonical ligands, EGF and TGFα. On the other hand, RNase 5 was identified as a new ligand of EGFR recently. However, the interplay between EGFR methylation and RNase 5 in EGFR activation is still unclear. Here, we showed that RNase 5 activated EGFR and enhanced cell proliferation in colorectal cancer cells. PRMT1 positively regulated EGFR signaling activation by RNase 5. Inhibition of EGFR methylation by methylation-site mutagenesis reduced the binding affinity of RNase 5 to EGFR and abrogated RNase 5-mediated EGFR activation, suggesting that PRMT1-mediated EGFR methylation is critical for EGFR activation by RNase 5. Notably, RNase 5 diminished the inhibitory activity of cetuximab on colorectal cancer cells, implying RNase 5 is a potential biomarker to predict cetuximab response in colorectal cancer.
Source: Europe PMC (PubMed Central)
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: Training Grant in Cancer Biology, Negative regulation of C-type lectin receptor signaling in response to fungal infection, Rational Combination Therapy with PARP Inhibitors in Triple Negative Breast Cancer, Mechanical Drugs: Harnessing Cancer Aggressiveness to Overcome Its Resistance, Cancer Center Support Grant
OpenAlex ID: W2998483933
